Literature DB >> 18223123

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.

Tejas Parikh1, Stephen J Drew, Vivian S Lee, Samson Wong, Elizabeth M Hecht, James S Babb, Bachir Taouli.   

Abstract

PURPOSE: To retrospectively compare diffusion-weighted (DW) magnetic resonance (MR) imaging with standard breath-hold T2-weighted MR imaging for focal liver lesion (FLL) detection and characterization, by using consensus evaluation and other findings as the reference standard.
MATERIALS AND METHODS: Approval for this retrospective HIPAA-compliant study was obtained from the institutional review board; informed consent was waived. Fifty-three consecutive patients (30 men, 23 women; mean age, 60.7 years) with at least one FLL of 1 cm or greater in diameter were evaluated. Two independent observers reviewed DW (b values of 0, 50, and 500 sec/mm(2)) and T2-weighted images for FLL detection and characterization. Reference standard for diagnosis was obtained from consensus review by the two observers of DW, T2-weighted, and dynamic contrast material-enhanced images, pathologic data, and follow-up imaging results. Apparent diffusion coefficient (ADC) was measured for FLLs identified at consensus review. DW and T2-weighted images were compared for FLL detection and characterization by using a binary logistic regression model. Receiver operating characteristic curve analyses were conducted to evaluate the utility of ADC for diagnosis of malignancy.
RESULTS: Two hundred eleven FLLs (136 malignant, 75 benign) were detected at consensus review. Overall detection rate (averaged for two observers) was significantly higher for DW (87.7%) versus T2-weighted (70.1%) imaging (P < .001). FLL characterization was not significantly different between DW (89.1%) and T2-weighted (86.8%) imaging (P = .51). ADCs of malignant FLLs were significantly lower than those of benign FLLs (P < .001). The area under the curve for diagnosis of malignancy was 0.839, with sensitivity of 74.2%, specificity of 77.3%, positive predictive value of 85.5%, negative predictive value of 62.3%, and accuracy of 75.3%, by using a threshold ADC of less than 1.60 x 10(-3) mm(2)/sec.
CONCLUSION: DW MR imaging was better than standard breath-hold T2-weighted imaging for FLL detection and was equal to breath-hold T2-weighted imaging for FLL characterization. (c) RSNA, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223123     DOI: 10.1148/radiol.2463070432

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  142 in total

Review 1.  "Vanishing liver metastases"-A real challenge for liver surgeons.

Authors:  Alex Zendel; Eylon Lahat; Yael Dreznik; Barak Bar Zakai; Rony Eshkenazy; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.

Authors:  D-M Koh; D J Collins; T Wallace; I Chau; A M Riddell
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

3.  The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study.

Authors:  Maïté Lewin; Laetitia Fartoux; Alexandre Vignaud; Lionel Arrivé; Yves Menu; Olivier Rosmorduc
Journal:  Eur Radiol       Date:  2010-08-05       Impact factor: 5.315

4.  Sclerosed hemangioma of the liver: possible diagnostic value of diffusion-weighted magnetic resonance imaging.

Authors:  Tomoyuki Hida; Akihiro Nishie; Tsuyoshi Tajima; Akinobu Taketomi; Shin-ichi Aishima; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2010-05-01       Impact factor: 2.374

Review 5.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

6.  Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma.

Authors:  Xing-Yu Cui; Hong-Wei Chen
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

7.  The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver.

Authors:  S A Choi; S S Lee; I-H Jung; H A Kim; J H Byun; M-G Lee
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

8.  Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Authors:  Santhi Maniam; Janio Szklaruk
Journal:  World J Radiol       Date:  2010-08-28

9.  Effect of imaging parameters on the accuracy of apparent diffusion coefficient and optimization strategies.

Authors:  Azim Celik
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

10.  Role of the apparent diffusion coefficient measurement by diffusion weighted magnetic resonance imaging in the diagnosis of Fasciola hepatica in the liver.

Authors:  Mehmet Ruhi Onur; Mehtap Ciçekçi; Alperen Kayali; Ercan Kocakoç; Cem Aygün
Journal:  Jpn J Radiol       Date:  2011-10-19       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.